학술논문
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient
Document Type
Article
Author
Source
In: Cancers . (Cancers, February 2024, 16(4))
Subject
Language
English
ISSN
20726694